Eisai

HALAVEN

View Prices
  1. Home
    2.  / 
  2. J Code
    3.  / HALAVEN – J9179

Manufacturer:

Eisai

Name:

HALAVEN

HCPCS Code Descriptor:

Injection, eribulin mesylate, 0.1 mg

Category:

J Code

HCPCS:

J9179

NDC(s):

62856-0389-01

Primary Type:

Oncology

Generic Status:

Single-Source

Route of Administration:

Intravenous

About:

HALAVEN is an Oncology drug manufactured by Eisai and administered via the Intravenous route of administration. The J Code: J9179 is aligned to the drug HALAVEN.

View Prices

Access Pricing and More By Registering

Register Now

HCPCS Added Date:

1/1/12

HCPCS Effective Date:

1/1/12

HCPCS Short Description:

Eribulin mesylate injection

Billing and Coding Guide:

https://www.eisaipatientsupport.com/hcp/halaven/billing-and-coding

Patient Assistance:

http://www.eisaireimbursement.com/

HALAVEN - J9179